Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

M.D. Anderson Cancer Center · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
hematopoietic cell transplantation recipient, refractory b-cell non-hodgkin lymphoma, refractory hodgkin lymphoma, refractory t-cell non-hodgkin lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 916057
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.